Abstract
Lysozyme is an abundant, cationic antimicrobial protein that plays an important role in host defense. It targets the β (1–4) glycosidic bond between N-acetylglucosamine and N-acetylmuramic residues that make up peptidoglycan, making lysozyme highly active against Gram-positive bacteria. However, lysozyme alone is inactive against Gram-negative bacteria because it cannot reach the peptidoglycan layer. Cecropins are cationic molecules with a wide range of antimicrobial activities. The main target for these peptides is the cytoplasmic membrane. We resume that cecopin may disrupt the outer membrane, giving the enzyme access to the peptidoglycan in cell wall. So in the present study, novel hybrid protein combining Musca domestica cecropin (Mdc) with human lysozyme (Hly) was designed. The DNA sequence encoding recombination fusion protein Mdc–hly was cloned into the pET-32a vector for protein expression in Escherichia coli strain BL21 (DE3). The protein was expressed as a His-tagged fusion protein, and the Mdc–hly was released from the fusion by enterokinase cleavage and separated from the carrier thioredoxin. Antimicrobial activity assays showed that the recombinant fusion protein Mdc–hly has improved in vitro antimicrobial activity and action spectrum compared to Mdc and hly. Mdc–hly may have important potential application as a future safely administered human drug and food additive.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Explore related subjects
Discover the latest articles and news from researchers in related subjects, suggested using machine learning.References
Arcidiacono S, Soares JW, Meehan AM, Marek P, Kirby R (2009) Membrane permeability and antimicrobial kinetics of cecropin P1 against Escherichia coli. J Pept Sci 15:398–403
Bastos M, Bai G, Gomes P, Andreu D, Goormaghtigh E, Prieto M (2008) Energetics and partition of two cecropin–melittin hybrid peptides to model membranes of different composition. Biophys J 94:2128–2141
Chen LY (2009) Monitoring conformational changes of immobilized RNase A and lysozyme in reductive unfolding by surface plasmon resonance. Anal Chim Acta 631:96–101
Chen X, Niyonsaba F, Ushio H, Okuda D, Nagaoka I, Ikeda S, Okumura K, Ogawa H (2005) Synergistic effect of antibacterial agents human beta-defensins, cathelicidin LL-37 and lysozyme against Staphylococcus aureus and Escherichia coli. J Dermatol Sci 40:123–132
Ferre R, Melo MN, Correia AD, Feliu L, Bardaji E, Planas M, Castanho M (2009) Synergistic effects of the membrane actions of cecropin–melittin antimicrobial hybrid peptide BP100. Biophys J 96:1815–1827
Gao FS, Fang QM, Li YG, Li XS, Hao HF, Xia C (2006) Reconstruction of a swine SLA-I protein complex and determination of binding nonameric peptides derived from the foot-and-mouth disease virus. Vet Immunol Immunopathol 113:328–338
Gill AO, Holley RA (2000) Surface application of lysozyme, nisin, and EDTA to inhibit spoilage and pathogenic bacteria on ham and bologna. J Food Prot 63:1338–1346
Gregory SM, Cavenaugh A, Journigan V, Pokorny A, Almeida PF (2008) A quantitative model for the all-or-none permeabilization of phospholipid vesicles by the antimicrobial peptide cecropin A. J Food Prot 94:1667–1680
Guo TK, Zhao X, Xie XD, Chen ZH, Zhou CS, Wei LL, Zhang H (2007) The anti-proliferative effects of recombinant human lysozyme on human gastric cancer cells. J Int Med Res 35:353–360
Huang L, Ching CB, Jiang RR, Leong SSJ (2008) Production of bioactive human beta-defensin 5 and 6 in Escherichia coli by soluble fusion expression. Protein Expr Purif 61:168–174
Huang L, Leong SSJ, Jiang RR (2009) Soluble fusion expression and characterization of bioactive human beta-defensin 26 and 27. Appl Microbiol Biotechnol 84:301–308
Kisich KO, Howell MD, Boguniewicz M, Heizer HR, Watson NU, Leung DY (2007) The constitutive capacity of human keratinocytes to kill Staphylococcus aureus is dependent on beta-defensin 3. J Invest Dermatol 127:2368–2380
Liu PT, Modlin RL (2008) Human macrophage host defense against Mycobacterium tuberculosis. Curr Opin Immunol 20:371–376
Lonnerdal B (2006) Recombinant human milk proteins. Nestle Nutr Workshop Ser Pediatr Program 58:207–215, discussion 215–207
Masschalck B, Michiels CW (2003) Antimicrobial properties of lysozyme in relation to foodborne vegetative bacteria. Crit Rev Microbiol 29:191–214
Niyonsaba F, Ogawa H (2005) Protective roles of the skin against infection: implication of naturally occurring human antimicrobial agents beta-defensins, cathelicidin LL-37 and lysozyme. J Dermatol Sci 40:157–168
Park Y, Lee DG, Jang SH, Woo ER, Jeong HG, Choi CH, Hahm KS (2003) A Leu–Lys-rich antimicrobial peptide: activity and mechanism. Biochim Biophys Acta 1645:172–182
Park Y, Park SN, Park SC, Shin SO, Kim JY, Kang SJ, Kim MH, Jeong CY, Hahm KS (2006) Synergism of Leu–Lys rich antimicrobial peptides and chloramphenicol against bacterial cells. Biochim Biophys Acta 1764:24–32
Rodriguez-Hernandez MJ, Saugar J, Docobo-Perez F, de la Torre BG, Pachon-Ibanez ME, Garcia-Curiel A, Fernandez-Cuenca F, Andreu D, Rivas L, Pachon J (2006) Studies on the antimicrobial activity of cecropin A–melittin hybrid peptides in colistin-resistant clinical isolates of Acinetobacter baumannii. J Antimicrob Chemother 58:95–100
Sakamoto S, Taura F, Putalun W, Pongkitwitoon B, Tsuchihashi R, Morimoto S, Kinjo J, Shoyama Y, Tanaka H (2009) Construction and expression of specificity-improved single-chain variable fragments against the bioactive naphthoquinone, plumbagin. Biol Pharm Bull 32:434–439
Schmitt P, Mercado L, Diaz M, Guzman F, Arenas G, Marshall SH (2008) Characterization and functional recovery of a novel antimicrobial peptide (CECdir–CECret) from inclusion bodies after expression in Escherichia coli. Peptides 29:512–519
Szynol A, de Haard JJ, Veerman EC, de Soet JJ, van Nieuw Amerongen AV (2006) Design of a peptibody consisting of the antimicrobial peptide dhvar5 and a llama variable heavy-chain antibody fragment. Chem Biol Drug Des 67:425–431
Tang YM, Ning BT, Cao J, Shen HQ, Qian BQ (2007) Construction and expression of single-chain antibody derived from a new clone of monoclonal antibody against human CD14 in CHO cells. Immunopharmacol Immunotoxicol 29:375–386
Tian ZG, Dong TT, Teng D, Yang YL, Wang JH (2009) Design and characterization of novel hybrid peptides from LFB15(W4, 10), HP(2–20), and cecropin A based on structure parameters by computer-aided method. Appl Microbiol Biotechnol 82:1097–1103
Toke O (2005) Antimicrobial peptides: new candidates in the fight against bacterial infections. Biopolymers 80:717–735
van der Linden DS, Short D, Dittmann A, Yu PL (2009) Synergistic effects of ovine-derived cathelicidins and other antimicrobials against Escherichia coli O157:H7 and Staphylococcus aureus 1056 MRSA. Biotechnol Lett 31:1265–1267
Wang YL, Jiang Y, Yang D, Li WY, Gong TX, Feng Y, Jiang ZH, Li MY (2009) Purification and characterization of novel antifungal peptide, mouse beta defensin-1, in Escherichia coli. World J Microbiol Biotechnol 25:917–920
Wen Q, Ma L, Luo W, Zhou MQ, Wang XN (2008) Expression, purification, and refolding of recombinant fusion protein hIL-2/mGM-CSF. Biomed Environ Sci 21:509–513
Xiong YQ, Mukhopadhyay K, Yeaman MR, Adler-Moore J, Bayer AS (2005) Functional interrelationships between cell membrane and cell wall in antimicrobial peptide-mediated killing of Staphylococcus aureus. Antimicrob Agents Chemother 49:3114–3121
Xu X, Jin F, Yu X, Ji S, Wang J, Cheng H, Wang C, Zhang W (2007a) Expression and purification of a recombinant antibacterial peptide, cecropin, from Escherichia coli. Protein Expr Purif 53:293–301
Xu X, Jin F, Yu X, Ren S, Hu J, Zhang W (2007b) High-level expression of the recombinant hybrid peptide cecropinA(1–8)–magainin2(1–12) with an ubiquitin fusion partner in Escherichia coli. Protein Expr Purif 55:175–182
Yan RQ, Wu ZM, Fang QM, Zhang ZL, Zhang J, Li XS, Hao HF, Xia C (2008) Reconstruction of a chicken BF2 protein complex and identification of binding nonamer peptides derived from avian influenza virus hemagglutinin. Vet Immunol Immunopathol 126:91–101
Yanga Y, Tiana Z, Teng D, Zhang J, Wang J, Wang J (2009) High-level production of a candidacidal peptide lactoferrampin in Escherichia coli by fusion expression. J Biotechnol 139:326–331
Yoe SM, Kang CS, Han SS, Bang IS (2006) Characterization and cDNA cloning of hinnavin II, a cecropin family antibacterial peptide from the cabbage butterfly, Artogeia rapae. Comp Biochem Physiol B Biochem Mol Biol 144:199–205
Zhou L, Zhao Z, Li B, Cai Y, Zhang S (2009) TrxA mediating fusion expression of antimicrobial peptide CM4 from multiple joined genes in Escherichia coli. Protein Expr Purif 64:225–230
Acknowledgment
This work was supported by National Natural Science Foundation of China (No. 30671832).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lu, Xm., Jin, Xb., Zhu, Jy. et al. Expression of the antimicrobial peptide cecropin fused with human lysozyme in Escherichia coli . Appl Microbiol Biotechnol 87, 2169–2176 (2010). https://doi.org/10.1007/s00253-010-2606-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00253-010-2606-3